Daniel Chen: After a decade of immense progress for patients with cancer immunotherapy we are excited to publish a 10-year update, reflecting the complexity in the TME.

Daniel Chen, Founder of Engenuity Life Sciences, shared on LinkedIn:

“We wrote the Cancer Immunity Cycle in 2013– and the scientific framework continues to hold up to time. After a decade of immense progress for patients with cancer immunotherapy we are excited to publish a 10Y update, reflecting the complexity in the TME.

It was an enormous effort to put together- and an incredible sprint at the end to finish. A big thanks to my co-authors Ira Mellman, Tom Powles, Shannon Turley.

And Thank You to Cell Press immunity Fabiola Rivas, Allison Bruce and all the authors that contributed to this special issue of Immunity!”

For the article click here.
Source: Daniel Chen/LinkedIn